Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026)
Dexcom (DXCM) posted quarterly Other Non-Current Liabilities of $150.8 million for Q2 2026, down 0.53% year-over-year from $151.6 million in Q2 2025, and up 6.35% quarter-over-quarter from $141.8 million in Q1 2026.
Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Other Non-Current Liabilities for 17 consecutive years, with $150.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Liabilities fell 0.53% year-over-year to $150.8 million; the TTM figure through Jun 2026 stood at $150.8 million (down 0.53% YoY), while the FY2025 annual figure was $137.1 million, down 7.3% from the prior year.
- Other Non-Current Liabilities rose to $150.8 million in Q2 2026 per DXCM's latest filing, from $141.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $151.6 million in Q2 2025 and bottomed at $97.1 million in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $132.5 million across 5 years, with a median of $131.4 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 42.56% — and 2025, when it fell 7.3%.
- Dexcom's Other Non-Current Liabilities stood at $128.3 million in 2022, then decreased by 2.1% to $125.6 million in 2023, then advanced by 17.75% to $147.9 million in 2024, then slipped by 7.3% to $137.1 million in 2025, then advanced by 9.99% to $150.8 million in 2026.
- Business Quant data shows DXCM's Other Non-Current Liabilities at $150.8 million in Q2 2026, $141.8 million in Q1 2026, and $137.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150.80 Mn |
| Mar 31, 2026 | 141.80 Mn |
| Dec 31, 2025 | 137.10 Mn |
| Sep 30, 2025 | 147.40 Mn |
| Jun 30, 2025 | 151.60 Mn |
| Mar 31, 2025 | 150.30 Mn |
| Dec 31, 2024 | 147.90 Mn |
| Sep 30, 2024 | 129.60 Mn |
| Jun 30, 2024 | 128.10 Mn |
| Mar 31, 2024 | 129.40 Mn |
| Dec 31, 2023 | 125.60 Mn |
| Sep 30, 2023 | 133.90 Mn |
| Jun 30, 2023 | 133.10 Mn |
| Mar 31, 2023 | 129.70 Mn |
| Dec 31, 2022 | 128.30 Mn |
| Sep 30, 2022 | 123.30 Mn |
| Jun 30, 2022 | 99.50 Mn |
| Mar 31, 2022 | 97.10 Mn |
| Dec 31, 2021 | 90.00 Mn |
| Sep 30, 2021 | 98.50 Mn |